<!DOCTYPE html>
<html lang="en" dir="auto">

<head><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>Pharmaceutical Industry | Behaviorism and Mental Health</title>
<meta name="keywords" content="">
<meta name="description" content="Alternative perspective on psychiatry&#39;s so-called mental disorders | PHILIP HICKEY, PH.D.">
<meta name="author" content="">
<link rel="canonical" href="https://www.behaviorismandmentalhealth.com/categories/pharmaceutical-industry/">
<link crossorigin="anonymous" href="../../assets/css/stylesheet.2211ca3164be7830024f6aad2b3a2e520843a64f8f048445c3401c1249aa051d.css" integrity="sha256-IhHKMWS&#43;eDACT2qtKzouUghDpk&#43;PBIRFw0AcEkmqBR0=" rel="preload stylesheet" as="style">
<link rel="icon" href="https://www.behaviorismandmentalhealth.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://www.behaviorismandmentalhealth.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://www.behaviorismandmentalhealth.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://www.behaviorismandmentalhealth.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://www.behaviorismandmentalhealth.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" type="application/rss+xml" href="https://www.behaviorismandmentalhealth.com/categories/pharmaceutical-industry/index.xml">
<link rel="alternate" hreflang="en" href="https://www.behaviorismandmentalhealth.com/categories/pharmaceutical-industry/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:url" content="https://www.behaviorismandmentalhealth.com/categories/pharmaceutical-industry/">
  <meta property="og:site_name" content="Behaviorism and Mental Health">
  <meta property="og:title" content="Pharmaceutical Industry">
  <meta property="og:description" content="Alternative perspective on psychiatry&#39;s so-called mental disorders | PHILIP HICKEY, PH.D.">
  <meta property="og:locale" content="en-us">
  <meta property="og:type" content="website">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Pharmaceutical Industry">
<meta name="twitter:description" content="Alternative perspective on psychiatry&#39;s so-called mental disorders | PHILIP HICKEY, PH.D.">

</head>

<body class="list" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://www.behaviorismandmentalhealth.com/" accesskey="h" title="Behaviorism and Mental Health (Alt + H)">Behaviorism and Mental Health</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)" aria-label="Toggle theme">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="https://www.behaviorismandmentalhealth.com/categories/" title="Categories">
                    <span>Categories</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main"> 
<header class="page-header">
  <h1>
    Pharmaceutical Industry
  </h1>
</header>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">The Mental Health Reform Act of 2016 (SB 2680) Would Be a Huge Step Backwards
    </h2>
  </header>
  <div class="entry-content">
    <p>On July 6, HB 2646 (the Tim Murphy Bill) passed the US House and was sent to the Senate.
At the present time, a related bill is working its way through the Senate. This is SB 2680, The Mental Health Reform Act 2016. It is sponsored by Lamar Alexander (R-TN), Patty Murray (D-WA), Bill Cassidy (R-LA), Chris Murphy (D-CT), David Vitter (R-LA), and Al Franken (D-MN). The wording of the bill was finalized in March of this year, and it passed out of committee on March 16.
...</p>
  </div>
  <footer class="entry-footer"><span title='2016-09-30 05:30:10 +0000 UTC'>September 30, 2016</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to The Mental Health Reform Act of 2016 (SB 2680) Would Be a Huge Step Backwards" href="https://www.behaviorismandmentalhealth.com/posts/the-mental-health-reform-act-of-2016-sb-2680-would-be-a-huge-step-backwards/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Allen Frances &#39;Replies&#39;
    </h2>
  </header>
  <div class="entry-content">
    <p>BACKGROUND
On June 19, 2015, I published a post titled Allen Frances’ Ties to Johnson &amp; Johnson. In that post, I set out some very serious allegations against Dr. Frances. I drew these allegations from a document titled Special Witness Report dated October 15, 2010. The report was written by David Rothman, PhD, Professor of Social Medicine at Columbia College of Physicians and Surgeons.
Dr. Rothman’s report was produced in the context of a lawsuit filed by the State of Texas against Janssen Pharmaceutica, a subsidiary of Johnson &amp; Johnson.
...</p>
  </div>
  <footer class="entry-footer"><span title='2015-06-24 05:30:39 +0000 UTC'>June 24, 2015</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Allen Frances &#39;Replies&#39;" href="https://www.behaviorismandmentalhealth.com/posts/allen-frances-replies/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Allen Frances&#39; Ties to Johnson &amp; Johnson
    </h2>
  </header>
  <div class="entry-content">
    <p>INTRODUCTION
I recently came across an article titled Diagnosisgate: Conflict of Interest at the Top of the Psychiatric Apparatus, by Paula Caplan, PhD. The article was published in Aporia, the University of Ottawa nursing journal, in January 2015. Aporia is “a peer-reviewed, bilingual, and open access journal dedicated to scholarly debates in nursing and the health sciences.”
Dr, Caplan is a clinical and research psychologist, and an Associate at Harvard’s DuBois Institute. She worked as a consultant to the DSM-IV task force in the 1980’s, but resigned from this position after two years. Here’s a quote from her February 2014 post on Mad in America The Great “Crazy” Cover-up: Harm Results from Rewriting the History of DSM:
...</p>
  </div>
  <footer class="entry-footer"><span title='2015-06-19 05:30:56 +0000 UTC'>June 19, 2015</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Allen Frances&#39; Ties to Johnson & Johnson" href="https://www.behaviorismandmentalhealth.com/posts/allen-frances-ties-to-johnson-johnson/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Pharma-funded Research
    </h2>
  </header>
  <div class="entry-content">
    <p>On August 20, 2014, Psychiatry Advisor published an article on its website. The article was written by Leslie Citrome, MD, a professor of psychiatry at New York Medical College in Valhalla, NY, and a member of the Board of Directors of the American Society of Clinical Psychopharmacology. The article is called Is Bias Against Pharma-Funded Research Fair? This is an interesting title, because bias, by its very definition, is unfair. So the very wording of the question begs the question – which strikes me as unfair. But let’s put that aside. ...</p>
  </div>
  <footer class="entry-footer"><span title='2014-09-26 05:30:46 +0000 UTC'>September 26, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Pharma-funded Research" href="https://www.behaviorismandmentalhealth.com/posts/pharma-funded-research/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">The FDA:  The Fox Guards the Hen House
    </h2>
  </header>
  <div class="entry-content">
    <p>In their Fall 2013 issue, the Journal of Law, Medicine, and Ethics published a symposium of papers by members of the Harvard’s Edmond J. Safra Center for Ethics. The symposium was called Institutional Corruption and Pharmaceutical Policy.
The symposium focuses on pharmaceutical products generally, but all the material is relevant and important in the context of psychiatric drugs.
In this post I will highlight one of these papers: Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs, by Donald W. Light, Joel Lexchin, and Jonathan J. Darrow.
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-05-07 05:58:15 +0000 UTC'>May 7, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to The FDA:  The Fox Guards the Hen House" href="https://www.behaviorismandmentalhealth.com/posts/the-fda-the-fox-guards-the-hen-house/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Sluggish Cognitive Tempo - A New Diagnosis?
    </h2>
  </header>
  <div class="entry-content">
    <p>On April 11, 2014, journalist Alan Schwarz (brief bio here) published an article in the New York Times on this topic, titled Idea of New attention Disorder Spurs Research, and Debate. Alan has written extensively on the rising rates of the condition known as ADHD, and on the abuse of the drugs that are used to “treat” this condition. He has drawn a good deal of criticism from psychiatry’s believers.
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-04-29 05:58:20 +0000 UTC'>April 29, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Sluggish Cognitive Tempo - A New Diagnosis?" href="https://www.behaviorismandmentalhealth.com/posts/sluggish-cognitive-tempo---a-new-diagnosis/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Revitalizing Psychiatric Therapeutics?
    </h2>
  </header>
  <div class="entry-content">
    <p>In January of this year, Steven Hyman MD, former Director of NIMH and currently a leading psychiatric researcher at MIT and Harvard, published Revitalizing Psychiatric Therapeutics in Neuropsychopharmacology. The article is in the journal’s commentary section and is essentially an opinion piece. Here’s Dr. Hyman’s summary:
&#34;Despite high prevalence and enormous unmet medical need, the pharmaceutical industry has recently de-emphasized neuropsychiatric disorders as &#39;too difficult&#39; a challenge to warrant major investment. Here I describe major obstacles to drug discovery and development including a lack of new molecular targets, shortcomings of current animal models, and the lack of biomarkers for clinical trials. My major focus, however, is on new technologies and scientific approaches to neuropsychiatric disorders that give promise for revitalizing therapeutics and may thus answer industry&#39;s concerns.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-02-10 05:57:15 +0000 UTC'>February 10, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Revitalizing Psychiatric Therapeutics?" href="https://www.behaviorismandmentalhealth.com/posts/revitalizing-psychiatric-therapeutics/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Sandy Hook Massacre:  The Unanswered Question
    </h2>
  </header>
  <div class="entry-content">
    <p>On December 27, 2013, Connecticut State Police issued a 7,000-page, heavily redacted, report on the massacre that occurred at Sandy Hook Elementary School just over a year earlier (December 14, 2012). For the record, I have not read the 7,000-page report, but I have read the Wikipedia article Sandy Hook Elementary School shooting, last updated January 4, 2013, and several media reports on the matter, including reports from the New York Times, the Hartford Courant, and the Washington Post.
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-01-06 05:50:32 +0000 UTC'>January 6, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Sandy Hook Massacre:  The Unanswered Question" href="https://www.behaviorismandmentalhealth.com/posts/sandy-hook-massacre-the-unanswered-question/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Psychiatry&#39;s Over Reliance On Pharma
    </h2>
  </header>
  <div class="entry-content">
    <p>I recently read The NIMH-CATIE Schizophrenia Study: What Did We Learn? by Jeffrey Lieberman, MD, and T. Scott Stroup, MD, MPH. The article was published in the American Journal of Psychiatry 168:8, August 2011. Here are two quotes:
&#34;When the CATIE study was designed in 1999-2000, the prevailing opinion of researchers and clinicians alike was that the newer (second-generation) antipsychotic drugs were vastly superior to the older (first-generation) antipsychotic drugs in efficacy and safety. This largely reflected the results of studies sponsored by the manufacturers of the new drugs…, marketing messages of pharmaceutical companies and the hopes of many who wanted better treatments.&#34;
...</p>
  </div>
  <footer class="entry-footer"><span title='2014-01-03 05:50:13 +0000 UTC'>January 3, 2014</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Psychiatry&#39;s Over Reliance On Pharma" href="https://www.behaviorismandmentalhealth.com/posts/psychiatry-s-over-reliance-on-pharma/"></a>
</article>

<article class="post-entry tag-entry"> 
  <header class="entry-header">
    <h2 class="entry-hint-parent">Neuroleptics for Children: Harvard&#39;s Shame
    </h2>
  </header>
  <div class="entry-content">
    <p>In December 2012, Mark Olfson, MD, et al, published an article in the Archives of General Psychiatry. The title is National Trends in the Office-Based Treatment of Children, Adolescents, and Adults with Antipsychotics. The authors collected data from the National Ambulatory Medical Care Surveys for the period 1993-2009, and looked for trends in antipsychotic prescribing for children, adolescents, and adults in outpatient visits. Here are the results:
Age Increase in no. of antipsychotic prescriptions per 100 population (1993-2009) 0-13 0.24-1.83 (almost 8-fold) 14-20 0.78-3.76 (almost 5-fold) 21&#43; 3.25-6.18 (almost 2-fold)   The authors provide a breakdown of the diagnoses assigned to the children and adolescents during the antipsychotic visits.
...</p>
  </div>
  <footer class="entry-footer"><span title='2013-12-04 05:58:42 +0000 UTC'>December 4, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD</footer>
  <a class="entry-link" aria-label="post link to Neuroleptics for Children: Harvard&#39;s Shame" href="https://www.behaviorismandmentalhealth.com/posts/neuroleptics-for-children-harvard-s-shame/"></a>
</article>
<footer class="page-footer">
  <nav class="pagination">
    <a class="next" href="https://www.behaviorismandmentalhealth.com/categories/pharmaceutical-industry/page/2/">Next&nbsp;&nbsp;»
    </a>
  </nav>
</footer>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="https://www.behaviorismandmentalhealth.com/">Behaviorism and Mental Health</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
